Esperion Therapeutics Inc (NASDAQ:ESPR)

6.56
Delayed Data
As of 4:00pm ET
 -0.145 / -2.16%
Today’s Change
3.28
Today|||52-Week Range
11.92
+31.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization236.0K252.0K258.0K265.0K
 
 
 
 
 
 
Operating ExpensesGross Income-236.0K-252.0K-258.0K-265.0K
 
 
 
 
 
General Expenses49.8M75.9M168.7M204.3M
 
 
 
 
 
Research And Development29.8M57.9M147.6M171.5M
 
 
 
 
 
Total Operating Expenses50.0M76.2M169.0M204.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-50.0M-76.2M-169.0M-204.6M
 
 
 
 
 
Interest Expense On Debt520.0K376.0K198.0K100.0K
 
 
 
 
 
Other Expenses-724.0K-1.1M-308.0K275.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-49.8M-75.0M-167.0M-201.8M
 
 
 
 
 
Net Income-49.8M-75.0M-167.0M-201.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.0M22.5M23.9M26.8M
 
 
 
 
 
Shares To Calculate EPS Diluted22.0M22.5M23.9M26.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.26-$3.33-$6.98-$7.54
 
 
 
 
 
EPS Diluted-$2.26-$3.33-$6.98-$7.54